#Japan #Tokyo #AI Development #Axon #Convano

Introduction

In the evolving landscape of medical technology, Convano Inc., based in Shibuya, Tokyo, is making significant strides with the establishment of a new internal organization titled the 'AI Development Room.' Set to officially commence operations on September 1, 2026, this initiative will focus on planning and developing products specifically designed for healthcare institutions using AI technology.

The Role of AXON

On August 28, 2026, Convano introduced its specialized AI agent system for healthcare institutions, known as AXON. The establishment of the AI Development Room aims to ensure the sustained enhancement of AXON’s functionalities and to provide dedicated support for its integration into medical facilities. Convano recognizes that merely providing the product is not sufficient; continuous support for functional development tailored to medical environments is crucial for AXON's long-term success within healthcare settings.

Formation of the AI Development Room

The AI Development Room will play a pivotal role in expanding AXON's capabilities and supporting its implementation into hospitals and clinics. This specialized unit allows for streamlined processes that address real-world challenges faced by healthcare professionals. Key aspects of its focus include:
1. Draft Support for Medical Records - AXON will help in drafting medical records based on consultation content.
2. Verification of Medical Claims - The AI system will assist in confirming the calculations necessary for medical reimbursement.
3. Integration Support for Medical Institutions - Providing the necessary guidance and tools for medical facilities to adopt AXON effectively.

Collaboration with Medical Professionals

A unique feature of the AI Development Room is its collaboration with physicians, who will be directly involved in the planning and development of AXON. By incorporating insights and experiences from medical practitioners into product development, Convano aims to ensure that AXON meets the practical needs of healthcare environments. This collaboration will drive the development of features that are directly applicable to day-to-day medical practices.

AI’s Role in Clinical Support

While AXON will offer drafting support for medical documentation, it is essential to note that the ultimate responsibility for validation and approval rests with the physicians. The goal is not to replace medical judgment with AI; instead, the system is designed to assist healthcare providers while ensuring that human oversight remains integral, thereby fostering a supportive environment where technology complements professional expertise.

Next Steps and Future Outlook

The setup of the AI Development Room is part of Convano's broader commitment to enhancing its existing business functions without incurring significant new costs. Consequently, the initiative is not expected to have a notable impact on the company's consolidated financial results for the fiscal year ending in March 2027.

About Convano, Inc.

Convano operates under the guiding philosophy of 'Creation Of New Value And New Opportunities.' It is a leader in AI, digital transformation (DX), and consulting, aiming to support corporate growth and operational transformation. By leveraging its extensive knowledge in business operations and data utilization, the company develops and supports AI system implementations, promotes DX initiatives, and provides management and marketing consulting. Convano is also expanding into new sectors, including healthcare, with practical solutions drawn from its expertise in operations, such as managing the nail service chain, 'FASTNAIL.'

Conclusion

As healthcare continues to evolve with the integration of advanced technologies like AI, Convano’s proactive steps in establishing the AI Development Room, paired with the expertise of medical professionals, will likely play a crucial role in shaping effective solutions for the future of patient care. By focusing on collaboration and functionality, Convano is set to enhance the efficacy of its medical AI offerings significantly.